🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

76,26 EUR

Máx. histórico

110,88

543 días

Caída desde máximo

-31,22%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,01%

Cierre anterior

76,27

Rango de hoy

75,90 – 76,65

Volumen hoy

1.490.914

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,54 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 2 días
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,40%
Fecha de pago Importe por participación
16/05/2011 2,5000 EUR
20/05/2010 2,4000 EUR
23/04/2009 2,2000 EUR
16/05/2008 2,0700 EUR
07/06/2007 1,7500 EUR
29/11/2006 0,2668 EUR
07/06/2006 1,5200 EUR
29/11/2005 0,2409 EUR
07/06/2005 1,2000 EUR
30/09/2004 0,0750 EUR
05/05/2004 1,4550 EUR
02/06/2003 0,8400 EUR
03/06/2002 0,6600 EUR
01/06/2001 0,4400 EUR
05/06/2000 0,3200 EUR
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/09/2002 60,72 61,46 59,08 59,13 -4,42% 3,93% 2.030.663
11/09/2002 59,62 62,41 58,38 61,86 +4,89% 6,76% 2.403.234
10/09/2002 57,78 59,13 56,99 58,98 +4,04% 3,70% 1.726.639
09/09/2002 57,29 57,98 55,50 56,69 -1,64% 4,34% 2.106.395
06/09/2002 55,80 57,64 54,80 57,64 +2,20% 5,08% 2.182.469
05/09/2002 56,59 56,69 53,71 56,39 +1,43% 5,27% 2.289.982
04/09/2002 53,71 56,49 53,21 55,60 +4,39% 6,11% 3.186.054
03/09/2002 54,70 54,70 52,36 53,26 -2,99% 4,27% 4.037.946
02/09/2002 57,68 57,68 53,91 54,90 -9,73% 6,55% 4.712.001
30/08/2002 59,67 61,17 58,48 60,82 +2,69% 4,50% 1.557.106
29/08/2002 60,37 61,02 57,98 59,23 -2,38% 5,02% 1.778.778
28/08/2002 61,71 62,01 60,27 60,67 -3,48% 2,82% 1.161.711
27/08/2002 61,71 63,11 60,67 62,86 +2,51% 3,95% 1.425.211
26/08/2002 62,51 64,35 61,22 61,32 -2,45% 5,01% 865.678
23/08/2002 64,25 64,25 62,31 62,86 -1,86% 3,02% 1.081.717
22/08/2002 62,36 64,05 61,71 64,05 +2,88% 3,75% 1.158.554
21/08/2002 61,76 64,15 61,36 62,26 +0,48% 4,51% 1.663.682
20/08/2002 64,15 64,95 61,71 61,96 -4,67% 5,04% 1.775.756
19/08/2002 64,15 65,09 63,11 64,99 +0,54% 3,10% 1.636.793
16/08/2002 64,15 65,39 63,65 64,65 +0,78% 2,71% 1.531.670
15/08/2002 64,65 64,99 63,65 64,15 +1,98% 2,08% 1.581.412
14/08/2002 63,35 64,99 62,36 62,91 -3,21% 4,16% 1.689.927
13/08/2002 63,65 64,99 62,26 64,99 +2,67% 4,30% 1.952.659
12/08/2002 64,80 65,44 62,41 63,30 -2,45% 4,68% 2.017.831
09/08/2002 64,15 64,90 61,36 64,90 +2,59% 5,50% 1.929.580
08/08/2002 64,85 65,49 61,41 63,25 -1,24% 6,29% 3.426.815
07/08/2002 63,16 64,85 62,66 64,05 +3,54% 3,46% 2.968.879
06/08/2002 57,83 62,36 56,79 61,86 +5,42% 9,63% 2.492.759
05/08/2002 59,62 60,72 57,19 58,68 +0,43% 5,92% 2.226.322
02/08/2002 57,78 59,92 57,09 58,43 +1,47% 4,91% 1.960.715